TheraRadar
Clinical-Stage Companies / Vigonvita Life Sciences

Vigonvita Life Sciences

Pre-Approval PRO BETA
31
Total Trials
3
Phase 3
5
Phase 2
5
Recruiting
174
Score

Pipeline by Phase

Phase 3
3
Phase 2
5
Phase 1
23

Therapeutic Focus

Erectile Dysfunction Healthy Subjects Pulmonary Arterial Hypertension Healthy Volunteers Schizophrenia

Clinical Trials (31)

NCT06301854 Phase 3 COMPLETED

Long-term Safety of TPN171H Tablet in Erectile Dysfunction.

Started: 4/12/2024

NCT05188989 Phase 3 COMPLETED

Efficacy and Safety Study of TPN171H Tablets in Erectile Dysfunction.

Started: 12/31/2021

NCT05341609 Phase 3 COMPLETED

Efficacy and Safety of JT001 (VV116) Compared With Paxlovid

Started: 4/4/2022

NCT06828887 Phase 2 RECRUITING

Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LV232 Capsules in the Treatment of MDD

Started: 4/3/2025

NCT06206720 Phase 2 COMPLETED

A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

Started: 1/31/2024

NCT04483115 Phase 2 COMPLETED

Acute Haemodynamic Study of TPN171H in Patients with Pulmonary Arterial Hypertension

Started: 11/16/2020

NCT04479917 Phase 2 COMPLETED

Efficacy and Safety of TPN171H in the Patients With Erectile Dysfunction

Started: 7/23/2020

NCT05388825 Phase 2 COMPLETED

Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction

Started: 8/1/2022

NCT07302269 Phase 1 RECRUITING

Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers

Started: 1/4/2026

NCT07240636 Phase 1 RECRUITING

Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Started: 11/28/2025

NCT06504290 Phase 1 RECRUITING

Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119

Started: 7/16/2024

NCT06105151 Phase 1 RECRUITING

Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers

Started: 10/27/2023

NCT07372703 Phase 1 NOT YET RECRUITING

Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants

Started: 2/1/2026

NCT06070857 Phase 1 COMPLETED

Study of the Safety, Tolerability, and Pharmacokinetics of LV232 Capsules in Chinese Healthy Volunteers

Started: 10/5/2023

NCT06279533 Phase 1 COMPLETED

Safety and Pharmacokinetics Study of Multiple Ascending Doses and Food Effect of LV232 Capsules

Started: 2/27/2024

NCT06749236 Phase 1 COMPLETED

A Study to Evaluate the Bioavailability of Two Specifications of Oral Deuremidevir Hydrobromide for Suspension

Started: 8/11/2025

NCT06476509 Phase 1 COMPLETED

A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET

Started: 5/30/2024

NCT05208814 Phase 1 COMPLETED

A Study to Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects

Started: 3/31/2022

NCT05932459 Phase 1 COMPLETED

A Study to Evaluate the Bioavailability, Food Effect and Pharmacokinetics of Deuremidevir Hydrobromide for Suspension

Started: 7/9/2023

NCT06328400 Phase 1 COMPLETED

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral Deuremidevir Hydrobromide for Suspension

Started: 3/27/2024

NCT06090123 Phase 1 COMPLETED

Drug-Drug Interaction (DDI) Study for TPN171H

Started: 1/1/2020

NCT06090136 Phase 1 COMPLETED

Safety and Pharmacokinetics of a Single Oral TPN171H in Healthy Elderly Subjects

Started: 9/14/2020

NCT05948644 Phase 1 COMPLETED

The Safety, Tolerability, and Pharmacokinetics of TPN171H Tablets in Patients With Pulmonary Arterial Hypertension

Started: 4/8/2019

NCT05750355 Phase 1 COMPLETED

Evaluate the Effect of TPN171H on the QT/QTc Interval in Healthy Volunteers

Started: 10/10/2022

NCT05585931 Phase 1 COMPLETED

Effect of TPN171H on Spermatogenesis

Started: 11/15/2022

NCT05227768 Phase 1 COMPLETED

Safety and Pharmacokinetics Study of Single Ascending Doses of VV116 in Healthy Volunteers

Started: 11/11/2021

NCT05316428 Phase 1 COMPLETED

A Study of the Hemodynamic Interactions of TPN171H Tablets & Alcohol in Healthy Male Subjects

Started: 2/24/2022

NCT05185011 Phase 1 COMPLETED

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

Started: 12/16/2021

NCT05201690 Phase 1 COMPLETED

Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV116 in Healthy Volunteers

Started: 12/14/2021

NCT05221138 Phase 1 COMPLETED

Food Effect on Pharmacokinetic Profiles of VV116 Administered Orally to Chinese Healthy Volunteers

Started: 12/30/2021

NCT04655872 Phase 1 COMPLETED

Mass Balance of Oral [14C]TPN171H in Healthy Male Subjects

Started: 11/26/2020

Drug Candidates

VV261 5mg group VV261 20mg Group VV261 50mg group VV261 100mg group VV261 150mg group VV261 300mg group VV261 500mg group VV261 750mg group VV261 1000mg group VV913 1mg group
Activity Status: Active
Last Trial Started: 2/1/2026
Last Trial Ended: 11/17/2025
Trials (12 months): 4
Completed Trials: 25
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.